Celina Dubin

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, published in the Journal of Investigative Dermatology (JID). The study evaluated differences in normal skin immune profiles across body locations that are amenable to antigen application and relevant in the context of skin biopsies in clinical trials.

Read the original paper here:

www.jidonline.org/article/S0022-202X(19)31498-8/fulltext

Drug-Induced Phototoxicity in Vitiligo: The Role of Hydrochlorothiazide in Photosensitivity Dermatitis.

Dr. Celina Dubin, MD, is a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai. She co-authored this study, which was published in Case Reports in Dermatological Medicine. The study examines the impact of hydrochlorothiazide, a thiazide diuretic commonly used as an antihypertensive agent, in photosensitivity dermatitis, a multifactorial condition characterized by an exaggerated cutaneous response to ultraviolet (UV) radiation, often exacerbated by exogenous agents, particularly photosensitizing medications. This case highlights the need to recognize drug-induced photosensitivity in vitiligo and to better understand how UV vulnerability and photosensitizing medications interact.

Read the Wiley Online Library version of the study here:

https://onlinelibrary.wiley.com/doi/full/10.1155/crdm/4302190/

Celina Dubin, MD, a resident physician in dermatology at the Icahn School of Medicine at Mount Sinai, co-authored this study, which was published in the Journal of the American Academy of Dermatology (JAAD).

Read the full case study here:

https://www.jaadcasereports.org/article/S2352-5126(25)00601-0/fulltext

Hair regrowth in endocrine therapy alopecia with dutasteride treatment in woman with estrogen positive breast cancer.

Celina Dubin MD & Angela Lamb MD

Read the full version here:

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10073935/

Or here:

https://www.jaadcasereports.org/article/S2352-5126(23)00078-4/fulltext

Also appears:

https://pubmed.ncbi.nlm.nih.gov/37034026/

Celina Dubin together with; Jacob W. Glickman, Dante Dahabreh, Joseph Han, Ester Del Duca, Yeriel D. Estrada, Ning Zhang, Grace W. Kimmel, Giselle Singer, James G. Krueger, Ana B. Pavel, & Emma Guttman-Yassky present a unique understanding of the phenotype of moderate-to-severe DoubleA with an integrated scalp and serum biomarker model suggesting the systemic nature of the disease, advocating for the need for immune-based systemic treatment.

Originally appeared in the Online Library: onlinelibrary.wiley.com/doi/10.1111/all.14814

ASN002 is an oral inhibitor of the Janus kinase/spleen tyrosine kinase signaling pathways, targeting several cytokine axes (T2/T22/T17/T1) and epidermal differentiation.

Originally appeared as a medical research paper:

www.pubfacts.com/detail/31356921/…l-barrier-marker

To characterize FFA compared to normal and alopecia areata, using broad molecular profiling, and to identify biomarkers linked to disease severity.

Originally published in PubMed:

pubmed.ncbi.nlm.nih.gov/34044102/

Stand SAFE 2022-

"Gun Violence Prevention Initiatives"

https://www.standsafe.org/the-team

"One of my earliest memories of Fiskebäckskil is being six years old, spending days sitting on the side of the road making a little store, like a lemonade stand. "

Celina Dubin recalls family vacations in Fiskebäckskil - originally appeared in Departures.com:

www.departures.com/archive/travel/…backskil-sweden

Firearms are a real "Health Threat" and require the research, education and policy-makin to keep us all healthy.

https://www.standsafe.org/the-team